Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.77M Sell
7,865
-1,319
-14% -$470K 0.07% 206
2025
Q4
$3.01M Buy
9,184
+1,581
+21% +$502K 0.1% 152
2025
Q3
$2.15M Sell
7,603
-38,347
-83% -$11.1M 0.1% 142
2025
Q2
$12.8M Buy
45,950
+542
+1% +$154K 0.86% 20
2025
Q1
$14.1M Buy
45,408
+2,468
+6% +$729K 1.42% 13
2024
Q4
$11.2M Buy
42,940
+2,087
+5% +$619K 1.35% 13
2024
Q3
$13.2M Sell
40,853
-449
-1% -$147K 2.67% 4
2024
Q2
$12.9M Buy
41,302
+1,902
+5% +$559K 4.21% 2
2024
Q1
$11.2M Buy
39,400
+103
+0.3% +$30.1K 6.46% 2
2023
Q4
$11.3M Buy
+39,297
New +$10.7M 10.99% 1

Other funds holding AMGN

Savvy Advisors Inc's AMGN Position: Q1 2026 in Review

Savvy Advisors Inc reduced its Amgen (AMGN) stake by 14% in Q1 2026, selling an estimated $470K and leaving 7,865 shares worth $2.77M. The position accounts for 0.07% of the portfolio, ranked #206.

Savvy Advisors Inc first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $14.1M in Q1 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Savvy Advisors Inc held 7,865 shares of Amgen worth $2.77M as of Q1 2026.
  • Savvy Advisors Inc sold 1,319 Amgen shares in Q1 2026, an estimated $470K.
  • Amgen made up 0.07% of Savvy Advisors Inc's portfolio in Q1 2026, its #206 holding.
  • Savvy Advisors Inc first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • Savvy Advisors Inc's Amgen position peaked at $14.1M in Q1 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Savvy Advisors Inc's 13F filing for Q1 2026, filed 11 May 2026.